Feasibility of 11C-acetate PET/CT for imaging of fatty acid synthesis in the atherosclerotic vessel wall

Journal of Nuclear Medicine

Volumn 52, Issue 12, 2011, Pages 1848-1854

  Derlin, Thorsten ^a   Habermann, Christian R ^a   Lengyel, Zsolt ^b   Busch, Jasmin D ^a   Wisotzki, Christian ^a   Mester, Janos ^a   Pávics, László ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Pozitron Ltd   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

11C acetate; Atherosclerosis; Calcification; Cardiovascular; Fatty acid synthase; PET CT

Indexed keywords

ACETIC ACID C 11; ACETYL COENZYME A; ACETIC ACID DERIVATIVE; CARBON; DIAGNOSTIC AGENT; FATTY ACID;

ADULT; ARTERY CALCIFICATION; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FATTY ACID SYNTHESIS; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MALE; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; AGED; ARTERY; ATHEROSCLEROSIS; BIOSYNTHESIS; CALCINOSIS; COHORT ANALYSIS; FEASIBILITY STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; RISK FACTOR; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL;

ACETATES; ADULT; AGED; ARTERIES; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CALCINOSIS; CARBON RADIOISOTOPES; COHORT STUDIES; FATTY ACIDS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 83755162312     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.095869     Document Type: Article

References (37)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics: 2010 update - a report from the American Heart Association. Circulation. 2010;121:e46-e215.
2. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2009;361:2252-2260.
3. Chen W, Bural GG, Torigian DA, et al. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2009;36:144-151.
4. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157-1166.
5. Felton CV, Crook D, Davies MJ, et al. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol. 1997;17:1337-1345. (Pubitemid 27329858)
6. Matter CM, Stuber M, Nahrendorf M. Imaging of the unstable plaque: how far have we got? Eur Heart J. 2009;30:2566-2574.
7. Tracy RE, Devaney K, Kissling G. Characteristics of the plaque under a coronary thrombus. Virchows Arch A Pathol Anat Histopathol. 1985;405:411-427. (Pubitemid 15119455)
8. Maseri A, Fuster V. Is there a vulnerable plaque? Circulation. 2003;107:2068-2071. (Pubitemid 36532183)
9. Trivedi RA, U-King-Im JM, Graves MJ, et al. MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology. 2004;46:738-743.
10. Perrone-Filardi P, Dellegrottaglie S, Rudd JH, et al. Molecular imaging of atherosclerosis in translational medicine. Eur J Nucl Med Mol Imaging. 2011;38:969-975.
11. Rominger A, Saam T, Wolpers S, et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med. 2009;50:1611-1620.
12. 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871-878.
13. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
14. 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur J Nucl Med Mol Imaging. 2009;36:1622-1628.
15. 18F- sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med. 2010;51:862-865.
16. Insull W Jr, Bartsch GE. Cholesterol, triglyceride, and phospholipid content of intima, media, and atherosclerotic fatty streak in human thoracic aorta. J Clin Invest. 1966;45:513-523.
17. Filipovic I, Rutemoller M. Comparative studies on fatty acid synthesis in atherosclerotic and hypoxic human aorta. Atherosclerosis. 1976;24:457-469.
18. Whereat AF. Lipid biosynthesis in aortic intima from normal and cholesterol-fed rabbits. J Atheroscler Res. 1964;4:272-282.
19. Semenkovich CF. Regulation of fatty acid synthase (FAS). Prog Lipid Res. 1997;36:43-53. (Pubitemid 27387114)
20. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104:503-516. (Pubitemid 32201946)
21. Ecker J, Liebisch G, Englmaier M, et al. Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc Natl Acad Sci USA. 2010;107:7817-7822.
22. Schneider JG, Yang Z, Chakravarthy MV, et al. Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. J Biol Chem. 2010;285:23398-23409.
23. 11C-choline. J Nucl Med. 2011;52:81-89.
24. 11C-acetate in rats with small-animal PET. J Nucl Med. 2006;47:477-485.
25. 1H-MR spectroscopy. J Nucl Med. 2010;51:1676-1683.
26. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831. (Pubitemid 44648621)
27. 18F-FDG uptake with vascular calcification. J Nucl Med. 2005;46:1278-1284.
28. 18F-FDG PET/CT. J Nucl Med. 2004;45:1816-1821.
29. 18F-Fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. J Nucl Med. 2011;52:1020-1027.
30. 18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries. Eur J Nucl Med Mol Imaging. 2006;33:1461-1467.
31. 18Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007;50:892-896.
32. Zheng J, El Naqa I, Rowold FE, et al. Quantitative assessment of coronary artery plaque vulnerability by high-resolution magnetic resonance imaging and computational biomechanics: a pilot study ex vivo. Magn Reson Med. 2005;54:1360-1368. (Pubitemid 41740765)
33. Ikeda Y, Yamamoto J, Okamura M, et al. Transcriptional regulation of the murine acetyl-CoA synthetase 1 gene through multiple clustered binding sites for sterol regulatory element-binding proteins and a single neighboring site for Sp1. J Biol Chem. 2001;276:34259-34269.
34. Saam T, Rominger A, Wolpers S, et al. Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study. Eur J Nucl Med Mol Imaging. 2010;37:1203-1212.
35. Yoshimoto M, Waki A, Obata A, et al. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl Med Biol. 2004;31:859-865. (Pubitemid 39297683)
36. Kuhajda FP, Pizer ES, Li JN, et al. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA. 2000;97:3450-3454. (Pubitemid 30183323)
37. Kridel SJ, Lowther WT, Pemble CW. Fatty acid synthase inhibitors: new directions for oncology. Expert Opin Investig Drugs. 2007;16:1817-1829. (Pubitemid 350187394)